CDKN2A Gene Melanoma Cutaneous Malignant Familial NGS Genetic DNA Test
Introduction to the CDKN2A Gene Melanoma Test
The CDKN2A Gene Melanoma Cutaneous Malignant Familial NGS Genetic DNA Test is an advanced genetic test that plays a vital role in identifying individuals at risk for melanoma, a severe form of skin cancer. This test utilizes Next-Generation Sequencing (NGS) technology to analyze the CDKN2A gene, which has been linked to familial melanoma syndromes. Understanding your genetic predisposition is essential for early detection and prevention strategies.
What the Test Measures
This test specifically measures mutations in the CDKN2A gene, which can indicate an increased risk of developing melanoma. By analyzing the genetic makeup, healthcare providers can better understand an individual’s risk and recommend appropriate monitoring and prevention strategies.
Who Should Consider This Test?
Individuals with a family history of melanoma or those who have experienced multiple skin cancers should consider this test. Symptoms that may warrant testing include:
- Multiple moles or unusual skin growths
- Family history of melanoma
- Fair skin, light hair, or a tendency to sunburn easily
Consulting with an oncologist or a genetic counselor is advisable to assess personal risk factors.
Benefits of Taking the Test
- Early identification of genetic risk factors for melanoma.
- Informed decision-making regarding surveillance and preventive measures.
- Potential for family members to understand their risk.
- Access to personalized treatment options based on genetic findings.
Understanding Your Results
Results from the CDKN2A Gene Melanoma Test will provide insights into whether genetic mutations are present. Positive results indicate a higher risk for melanoma, prompting discussions about increased surveillance and preventive measures with your healthcare provider. Negative results can offer reassurance but do not eliminate the risk entirely.
Test Details and Pricing
| Test Name | Discount Price | Regular Price |
|---|---|---|
| CDKN2A Gene Melanoma Cutaneous Malignant Familial NGS Genetic DNA Test | 400,000 NGN | 560,000 NGN |
Book Your Test Today!
Don’t leave your health to chance. Book your CDKN2A Gene Melanoma Cutaneous Malignant Familial NGS Genetic DNA Test today for only 400,000 NGN. For inquiries or to schedule your appointment, call or WhatsApp us at +2348110567037.
Additional Information
Turnaround Time: 3 to 4 Weeks
Sample Type: Blood or Extracted DNA or One drop Blood on FTA Card
Pre-test Instructions: A clinical history of the patient who is going for the test is required, along with a genetic counseling session to draw a pedigree chart of family members affected with CDKN2A Gene Melanoma.
Consult with an oncologist or genetic counselor to understand the implications of your test results fully.
